Ceramides, P CERAM

Synonyms
Allscripts (AEHR) Order Name	Ceramides, Plasma
Sunrise Clinical Manager (SCM) Order Name	Ceramides, Plasma
EPIC Order Name	Ceramides, P
Clinical Info	Evaluating for the risk of major adverse cardiovascular events within the next 1 to 5 years MI-Heart Ceramides is a blood test that measures risk for adverse cardiovascular events and quantifies plasma ceramides. Plasma ceramides are predictors of adverse cardiovascular events resulting from unstable atherosclerotic plaque.
Specimen Type
Specimen Volume	1 mL EDTA plasma ( 0.5 mL min)
Container	Lavender Top Tube
Collection Instructions	Collection Container/Tube: Lavender top (EDTA) Specimen : 1 mL EDTA Plasma (0.5 mL min) Transport Temperature: Frozen Collection Instructions: Freeze within 8 hours. Patient Preparation: Patients should not be receiving Intralipid because it may cause false-elevations in measured ceramides
Transport Instructions
Specimen Stability	8 Hours Room Temperature 1 Day Refrigerated 30 Days frozen
Methodology	Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)
Days Performed	TAT: 3-10 Days
Performing Laboratory	Mayo Clinic Laboratories
CPT	0119U LOINC Code: 93883-7
PDM	1859767
Result Interpretation MI-Heart Ceramide Risk Score: 0-2 Lower risk 3-6 Moderate risk 7-9 Increased risk 10-12 Higher risk Ceramide (16:0): 0.19-0.36 mcmol/L Ceramide (18:0): 0.05-0.14 mcmol/L Ceramide (24:1): 0.65-1.65 mcmol/L Ceramide (16:0)/(24:0): <0.11 Ceramide (18:0)/(24:0): <0.05 Ceramide (24:1)/(24:0): <0.45 Reference values have not been established for patients who are <18 years of age. Note: Ceramide (24:0) alone has not been independently associated with disease and will not be reported.
Forms